Quoin Pharmaceuticals, Ltd.
ASHBURN, VA · CIK 0001671502 · Biotech · Public
Small-molecule therapeutics for rare diseases
quoinpharma.com →- Grants
- —
- No SBIR or STTR on record
- Sector median: 1
- Raised
- $164M
- 5 Form D · Sep 2026
- 1 months since last filing
- Contracts
- —
- No federal contracts on record
- Patents
- —
- No published records under this name
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓201720192021202320252027
| Date | Event | Source | Amount |
|---|---|---|---|
| Private capital raised | Form D · SEC | $4,302,202 | |
| Private capital raised | Form D · SEC | $3,999,996 | |
| Private capital raised | Form D · SEC | $193,537 | |
| Private capital raised | Form D · SEC | $105,254,891 | |
| Private capital raised | Form D · SEC | $50,000,649 |
Form D · SEC
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 1745 | AVT, Inc. | — | $170K |
| 1746 | INFINIFLUIDICS INC | — | — |
| 1747 | Airway Therapeutics, LLC | — | $54M |
| 1748 | Quoin Pharmaceuticals, Ltd. | — | $164M |
| 1749 | Tempo Therapeutics Inc | — | $34M |
| 1750 | ASAKE BIOTECHNOLOGY, LLC | — | — |
| 1751 | ANTHROBIO, INC. | — | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
- Ruhama AvrahamDirector
- Ruth Ben YakarDirector
- Michael BerelowitzDirector
- Yuval BermanDirector
- David BraunDirector
- Denise CarterDirector · Executive Officer
- Kasbian ChirichDirector
- Joseph CooperDirector
- James CulverwellDirector
- Gordon DunnExecutive Officer
- David GrossmanDirector
- Dennis LangerDirector
- Sally LawlorExecutive Officer
- Eyal LeibovitzExecutive Officer
- Natalie LeongDirector
- Michael MyersDirector · Executive Officer
- Abraham NahmiasDirector
- Michael SemberDirector
- Shai YarkoniDirector · Executive Officer
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.